Published in J Mol Biol on February 28, 1971
Recalibrated linkage map of Escherichia coli K-12. Bacteriol Rev (1976) 35.30
Biosynthesis and metabolism of arginine in bacteria. Microbiol Rev (1986) 5.79
Divergent promoters, a common form of gene organization. Microbiol Rev (1988) 3.25
Regulation of the beta-glucoside system in Escherchia coli K-12. J Bacteriol (1974) 2.91
Identification of the tetracycline resistance promoter and repressor in transposon Tn10. J Bacteriol (1981) 2.77
Direction of transcription of the regulatory gene araC in Escherichia coli B-r. Proc Natl Acad Sci U S A (1974) 2.05
A mutant of Escherichia coli that requires high concentrations of biotin. Proc Natl Acad Sci U S A (1972) 1.78
Location and orientation of the phoA locus on the Escherichia coli K-12 linkage map. J Bacteriol (1971) 1.65
Deletion and complementation analysis of biotin gene cluster of Escherichia coli. J Bacteriol (1972) 1.57
Location of promoter and operator sites in the biotin gene cluster of Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.55
Biotinyl 5'-adenylate: corepressor role in the regulation of the biotin genes of Escherichia coli K-12. Proc Natl Acad Sci U S A (1979) 1.33
Biosynthesis of 7,8-diaminopelargonic acid, a biotin intermediate, from 7-keto-8-aminopelargonic acid and S-adenosyl-L-methionine. J Bacteriol (1971) 1.29
A deletion mutation placing the galactokinase gene of Escherichia coli under control of the biotin promoter. Proc Natl Acad Sci U S A (1974) 1.15
Mutant of Escherichia coli with derepressed levels of the biotin biosynthetic enzymes. J Bacteriol (1972) 1.10
Ribitol and D-arabitol catabolism in Escherichia coli. J Bacteriol (1978) 1.09
Repression of biotin biosynthesis in Escherichia coli during growth on biotin vitamers. J Bacteriol (1978) 1.08
Divergent orientation of transcription from the arginine gene ECBH cluster of Escherichia coli. J Bacteriol (1974) 1.07
In vitro synthesis and and regulation of the biotin enzymes of Escherichia coli K-12. J Bacteriol (1978) 1.03
Genetics of biotin biosynthesis in Bacillus subtilis. J Bacteriol (1975) 0.99
Mode of action of alpha-dehydrobiotin, a biotin analogue. J Bacteriol (1975) 0.97
Biotin uptake in biotin regulatory mutant of Escherichia coli. J Bacteriol (1973) 0.94
Biotinylation facilitates the uptake of large peptides by Escherichia coli and other gram-negative bacteria. Appl Environ Microbiol (2005) 0.91
Determination of the transcription direction of the exuT gene in Escherichia coli K-12: divergent transcription of the exuT-uxaCA operons. J Bacteriol (1982) 0.85
Physical mapping of the exuT and uxaC operators by use of exu plasmids and generation of deletion mutants in vitro. J Bacteriol (1983) 0.82
Genetic diversity within the genus Francisella as revealed by comparative analyses of the genomes of two North American isolates from environmental sources. BMC Genomics (2012) 0.79
Construction of a Biotin-Overproducing Strain of Serratia marcescens. Appl Environ Microbiol (1993) 0.78
Abortive termination of bioBFCD RNA synthesized in vitro from the bioABFCD operon of Escherichia coli K-12. Proc Natl Acad Sci U S A (1982) 0.77
The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature (1996) 3.40
Purification and biological activity of thymosin, a hormone of the thymus gland. Proc Natl Acad Sci U S A (1972) 3.24
Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone. Proc Natl Acad Sci U S A (1971) 3.13
Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg (1998) 2.17
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res (2001) 2.13
Controls and polarity of transcription during bacteriophage T4 development. J Mol Biol (1971) 1.77
Fractionation of the complementary strands of coliphage T4 DNA based on the asymmetric distribution of the poly U and poly U,G binding sites. Virology (1968) 1.75
Ontogenesis of cell-mediated immunity in murine thymocytes and spleen cells and its acceleration by thymosin, a thymic hormone. J Immunol (1971) 1.73
Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A (1987) 1.71
Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Neurosurgery (1999) 1.52
Orientation and control of transcription in E. coli phage lambda. Nature (1969) 1.43
Conservative management of vestibular schwannomas: third review of a 10-year prospective study. Clin Otolaryngol (2008) 1.33
An inhibitory monoclonal antibody against human tissue factor. Blood (1987) 1.30
Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Mol Cell Biol (1993) 1.29
In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest (1996) 1.26
Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs). Hum Mutat (2008) 1.25
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology (2002) 1.25
Transcriptional controls in developing bacteriophages. J Cell Physiol (1969) 1.25
Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J Exp Med (1989) 1.23
Orientation of transcription for the galactose operon as determined by hybridization of gal mRNA with the separated DNA strands of coliphages lambda-dg. J Mol Biol (1968) 1.21
Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex. Biochemistry (1992) 1.20
Identification of active tissue factor in human coronary atheroma. Circulation (1996) 1.18
Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology (1997) 1.14
Spontaneous in vitro transformation of human fibroblasts. J Natl Cancer Inst (1984) 1.14
Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. J Neuropathol Exp Neurol (2000) 1.14
Neurogenic sarcomas: experience at the University of Toronto. Neurosurgery (1998) 1.13
Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest (1993) 1.12
Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int J Cancer (1999) 1.10
Decompression of the spinal cord improves recovery after acute experimental spinal cord compression injury. Paraplegia (1987) 1.10
Divergent orientation of transcription from the arginine gene ECBH cluster of Escherichia coli. J Bacteriol (1974) 1.07
Glioblastoma multiforme occurring in a patient treated with gamma knife surgery. Case report and review of the literature. J Neurosurg (2001) 1.06
Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1. Neurology (2003) 1.05
Identification of the transcribing DNA strand for the rII and endolysin genes of coliphage T4. J Mol Biol (1968) 1.02
Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery (1997) 1.02
GATA4 is a regulator of astrocyte cell proliferation and apoptosis in the human and murine central nervous system. Oncogene (2009) 1.02
Purification and comparison of 2',3'-cyclic nucleotide 3'-phosphohydrolases from bovine brain and spinal cord. J Neurochem (1978) 1.01
Affinity purification of human tissue factor: interaction of factor VII and tissue factor in detergent micelles. Proc Natl Acad Sci U S A (1986) 1.01
Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects. Oncogene (1999) 1.00
The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta (1994) 0.99
Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J Clin Invest (1993) 0.98
Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol (1994) 0.98
Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor. Proc Natl Acad Sci U S A (1990) 0.98
Soft-tissue augmentation with injectable alginate and syngeneic fibroblasts. Plast Reconstr Surg (2000) 0.97
The effect of vitamin A deficiency and dietary alpha-tocopherol on the stability of rat-liver lysosomes. Biochem J (1965) 0.97
Expression and hypoxic regulation of angiopoietins in human astrocytomas. Neuro Oncol (2001) 0.96
Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas. Genes Chromosomes Cancer (1998) 0.96
Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis. Brain Res (2000) 0.95
Expression and regulation of neuropilin-1 in human astrocytomas. Int J Cancer (2000) 0.94
Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras. Oncogene (1996) 0.94
Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol (1991) 0.94
Isotype-specific Ras.GTP-levels predict the efficacy of farnesyl transferase inhibitors against human astrocytomas regardless of Ras mutational status. Cancer Res (2001) 0.93
Expression and activation of epidermal growth factor receptors in meningiomas. J Neurosurg (1997) 0.93
Intimal tissue factor activity is released from the arterial wall after injury. Thromb Haemost (2000) 0.92
Inhibition of angiogenesis by blocking activation of the vascular endothelial growth factor receptor 2 leads to decreased growth of neurogenic sarcomas. Cancer Res (1999) 0.92
Solubilization of 2',3'-cyclic nucleotide 3'-phosphohydrolase from bovine brain without detergents. Brain Res (1975) 0.92
Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway. Surg Neurol (1999) 0.91
Signal transduction pathways and their relevance in human astrocytomas. J Neurooncol (1997) 0.91
Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression. J Immunol (1986) 0.91
Conservative management of vestibular schwannomas - second review of a prospective longitudinal study. Clin Otolaryngol Allied Sci (2004) 0.89
Failed stereotactic biopsy in a series of 518 cases. Stereotact Funct Neurosurg (1995) 0.89
DNA: DNA hybridization method for the diagnosis of hepatitis B infection. J Virol Methods (1984) 0.88
Pheochromocytoma: observations on mechanism of carbohydrate intolerance and abnormalities associated with development of Goldblatt kidney following removal of tumor. Metabolism (1969) 0.88
Isolation and structure elucidation of a new antifungal and antibacterial antibiotic produced by Streptomyces sp. 201. Biosci Biotechnol Biochem (2001) 0.87
Isolation and characterization of the biotin genes of Escherichia coli K-12. Gene (1977) 0.87
Evidence of two operators in the biotin locus of Escherichia coli. Nat New Biol (1973) 0.87
Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. Hum Mol Genet (2001) 0.86
Mouse astrocytoma models: embryonic stem cell mediated transgenesis. J Neurooncol (2001) 0.85
Neurofibromatosis type 1: piecing the puzzle together. Can J Neurol Sci (1998) 0.85
Alterations in the rap1 signaling pathway are common in human gliomas. Oncogene (1997) 0.85
Effect of carrageenin on the incorporation of S-35-sulphate and C14-glucose into cultivated connective tissue mucopolysaccharides. Indian J Biochem (1964) 0.85
Isolation of the regulatory segment of the biotin operons of Escherichia coli K-12. Gene (1978) 0.85
Primary intracranial fibrosarcoma with intratumoral hemorrhage: neuropathological diagnosis with review of the literature. J Neurooncol (1997) 0.84
Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response. J Immunol (1986) 0.84
Activation of factor X by factor VIIa complexed with human-mouse tissue factor chimeras requires human exon 3. Thromb Haemost (1996) 0.83
The influence of alpha-tocopherol on arylsulfatases A and B in the liver of vitamin A-deficient rats. Biochim Biophys Acta (1965) 0.83
Fructose-diphosphate aldolase from lobster muscle. Methods Enzymol (1975) 0.83
Solitary condylomatous papilloma of the bronchus. Arch Pathol Lab Med (1988) 0.82
Detection of activated platelet-derived growth factor receptors in human meningioma. Cancer Res (1997) 0.82
Solitary metastasis to the choroid plexus. Case illustration. J Neurosurg (2000) 0.81
Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas. Ann Neurol (1997) 0.81
Asymmetric transcription during development of F1, a bacteriophage specific for Clostridium sporogenes. Virology (1974) 0.81
Lobster muscle aldolase: isolation, properties and primary structure at the substrate-binding site. Arch Biochem Biophys (1971) 0.81
Cell-mediated amplification and down regulation of cytotoxic immune response against autologous human cancer. J Immunol (1987) 0.81
Activation of blood coagulation factor VIIa with cleaved tissue factor extracellular domain and crystallization of the active complex. Proteins (1995) 0.80
Characterization of the mRNA transcribed from the head and tail genes of phage lambda chromosome. Nat New Biol (1973) 0.80
Acute myelomonocytic leukemia associated with nephrotic syndrome. A case report with immunological studies. Nephron (1983) 0.80
A persistent median artery causing carpal tunnel syndrome in a patient with chronic renal failure: case report. Neurosurgery (1995) 0.79
Assessment of spinal cord injury by counting corticospinal and rubrospinal neurons. Brain Res (1987) 0.79
Mucinous, gland predominant synovial sarcoma of a large peripheral nerve: a rare case closely mimicking metastatic mucinous carcinoma. J Clin Pathol (2008) 0.79
Purification and mode of action of exoribonuclease from bovine brain. J Biol Chem (1977) 0.79
Isolation and sequence determination of 5'-terminal oligonucleotide fragments of RNA transcripts synthesized by bacteriophage T3-induced RNA polymerase from T3 DNA. Proc Natl Acad Sci U S A (1980) 0.79
Synthesis of prostaglandin E by peritoneal macrophages from NZB/W mice. Life Sci (1988) 0.79
Anaesthesia for endovascular management of cerebral aneurysms. Eur J Anaesthesiol (2006) 0.78
Hypercalcemia during the diuretic phase of acute renal failure. Med Ann Dist Columbia (1973) 0.78
Effect of a calcium channel blocker on posttraumatic spinal cord blood flow. J Neurosurg (1987) 0.78
Activation of autoreactive cytolytic T lymphocyte clone against human melanoma by anti-T3 monoclonal antibody and autologous accessory cells. Cell Immunol (1987) 0.78
Evidence for the early synthesis of T4 bacterio- phage-coded transfer RNA. Biochem Biophys Res Commun (1970) 0.78
Optimal concentration of epidural fentanyl in bupivacaine 0.1% after thoracotomy. Br J Anaesth (2004) 0.78
Prehospital care of trauma must be improved in UK. BMJ (2001) 0.77